Lv3
394 积分 2026-03-16 加入
Virtual Bioequivalence Assessment of Long-Acting Injectable Suspensions Using PBPK Modeling: Part 2. Type I Error and Safe Space Analyses
9小时前
已完结
Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified‐Release Dosage Form
9小时前
已关闭
New Model–Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling
10小时前
已完结
Virtual Bioequivalence Assessment of Long-Acting Injectable Suspensions Using PBPK Modeling: Part 2. Type I Error and Safe Space Analyses
15小时前
已完结
Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points
13天前
已完结
Clinical Pharmacokinetics of Metoprolol: A Systematic Review
20天前
已完结
Sample Size Determination and Study Design Impact on Dose-Scale Pharmacodynamic Bioequivalence: a Case Study Using Orlistat
1个月前
已完结
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
1个月前
已完结
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
1个月前
已完结
Efficient model-based bioequivalence testing
1个月前
已完结
皖公网安备34019202002308
